AAVXF
Price
$104.95
Change
+$2.00 (+1.94%)
Updated
Nov 12 closing price
Capitalization
8.19B
Intraday BUY SELL Signals
CNSP
Price
$6.45
Change
-$0.14 (-2.12%)
Updated
Nov 13 closing price
Capitalization
3.71M
Intraday BUY SELL Signals
Interact to see
Advertisement

AAVXF vs CNSP

Header iconAAVXF vs CNSP Comparison
Open Charts AAVXF vs CNSPBanner chart's image
Abivax SA
Price$104.95
Change+$2.00 (+1.94%)
Volume$125
Capitalization8.19B
CNS Pharmaceuticals
Price$6.45
Change-$0.14 (-2.12%)
Volume$8.69K
Capitalization3.71M
AAVXF vs CNSP Comparison Chart in %
AAVXF
Daily Signal:
Gain/Loss:
CNSP
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AAVXF vs. CNSP commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a StrongBuy and CNSP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AAVXF: $104.95 vs. CNSP: $6.45)
Brand notoriety: AAVXF and CNSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 9% vs. CNSP: 25%
Market capitalization -- AAVXF: $8.19B vs. CNSP: $3.71M
AAVXF [@Biotechnology] is valued at $8.19B. CNSP’s [@Biotechnology] market capitalization is $3.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 1 FA rating(s) are green whileCNSP’s FA Score has 2 green FA rating(s).

  • AAVXF’s FA Score: 1 green, 4 red.
  • CNSP’s FA Score: 2 green, 3 red.
According to our system of comparison, both AAVXF and CNSP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAVXF’s TA Score shows that 3 TA indicator(s) are bullish while CNSP’s TA Score has 4 bullish TA indicator(s).

  • AAVXF’s TA Score: 3 bullish, 3 bearish.
  • CNSP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AAVXF is a better buy in the short-term than CNSP.

Price Growth

AAVXF (@Biotechnology) experienced а +1.94% price change this week, while CNSP (@Biotechnology) price change was -6.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.64%. For the same industry, the average monthly price growth was -3.56%, and the average quarterly price growth was +66.73%.

Industries' Descriptions

@Biotechnology (+3.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($8.19B) has a higher market cap than CNSP($3.71M). AAVXF YTD gains are higher at: 849.774 vs. CNSP (-91.071). CNSP has higher annual earnings (EBITDA): -15.44M vs. AAVXF (-170.04M). AAVXF has more cash in the bank: 104M vs. CNSP (12.1M). CNSP has less debt than AAVXF: CNSP (122K) vs AAVXF (92.6M). AAVXF (0) and CNSP (0) have equivalent revenues.
AAVXFCNSPAAVXF / CNSP
Capitalization8.19B3.71M220,663%
EBITDA-170.04M-15.44M1,101%
Gain YTD849.774-91.071-933%
P/E RatioN/A0.00-
Revenue00-
Total Cash104M12.1M860%
Total Debt92.6M122K75,902%
FUNDAMENTALS RATINGS
AAVXF vs CNSP: Fundamental Ratings
AAVXF
CNSP
OUTLOOK RATING
1..100
3650
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
7
Undervalued
PROFIT vs RISK RATING
1..100
19100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3465
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
n/a5

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNSP's Valuation (7) in the null industry is somewhat better than the same rating for AAVXF (55). This means that CNSP’s stock grew somewhat faster than AAVXF’s over the last 12 months.

AAVXF's Profit vs Risk Rating (19) in the null industry is significantly better than the same rating for CNSP (100). This means that AAVXF’s stock grew significantly faster than CNSP’s over the last 12 months.

AAVXF's SMR Rating (99) in the null industry is in the same range as CNSP (100). This means that AAVXF’s stock grew similarly to CNSP’s over the last 12 months.

AAVXF's Price Growth Rating (34) in the null industry is in the same range as CNSP (65). This means that AAVXF’s stock grew similarly to CNSP’s over the last 12 months.

CNSP's P/E Growth Rating (8) in the null industry is significantly better than the same rating for AAVXF (100). This means that CNSP’s stock grew significantly faster than AAVXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AAVXFCNSP
RSI
ODDS (%)
Bearish Trend 2 days ago
23%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
32%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
33%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
29%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
37%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AAVXF
Daily Signal:
Gain/Loss:
CNSP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMN14.340.22
+1.55%
ProShares UltraShort Materials
BBAG46.57-0.13
-0.28%
JPMorgan BetaBuilders US Aggt Bond ETF
JANW36.38-0.15
-0.41%
AllianzIM US Large Cap Buffer20 Jan ETF
PDBA34.90-0.24
-0.67%
Invesco Agriculture Cmdty Str No K-1ETF
YSPY18.95-0.23
-1.19%
GraniteShares YieldBOOST SPY ETF

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
N/A
BPMUF - AAVXF
47%
Loosely correlated
N/A
MLEC - AAVXF
38%
Loosely correlated
-5.00%
CNSP - AAVXF
34%
Loosely correlated
-2.12%
ACHV - AAVXF
28%
Poorly correlated
-2.97%
GMAB - AAVXF
24%
Poorly correlated
-0.75%
More

CNSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNSP has been loosely correlated with PMN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CNSP jumps, then PMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNSP
1D Price
Change %
CNSP100%
-2.12%
PMN - CNSP
50%
Loosely correlated
-4.94%
VIR - CNSP
36%
Loosely correlated
-4.20%
AAVXF - CNSP
34%
Loosely correlated
N/A
MURA - CNSP
31%
Poorly correlated
+0.48%
PTGX - CNSP
30%
Poorly correlated
-1.90%
More